Related Experiment Video
Updated: Aug 19, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Overdose of lomustine: report of two cases
Abdullah Büyükçelik1, Hakan Akbulut, Bülent Yalçin
1Department of Medical Oncology, Ankara University School of Medicine, Ibni Sina Hospital, Ankara, Turkey. drabdullah@superposta.com
Abstract:
Two male patients with high-grade gliomas were treated with subtotal or total resection and radiotherapy followed by a lomustine-containing chemotherapy regimen. Both patients took lomustine at an oral dose of 800 mg over five days instead of their regular doses of 200 and 240 mg. Grade 4 neutropenia and thrombocytopenia developed in both patients within two weeks of the last lomustine dose. One of them was admitted to hospital because of febrile neutropenia. Neutropenia and thrombocytopenia were detected in the other patient when he was examined in the emergency room following a generalized convulsion. Both patients recovered from the severe myelosuppression caused by lomustine. No other organ toxicities were observed.
Related Concept Videos
Drug Toxicity: Risk factors
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Overview
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Allergic Reactions
Dosage Regimen: Multiple Oral Dosage